Developer docs
API playgroundTry for free, no card

Search company profiles

Gradient Health

Full company profile

uuid0000luc

Namestring
Gradient Health
Legal namestring
Gradient Health, Inc.
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Gradient Health, Inc. is a Delaware-incorporated medical AI data platform headquartered in Durham, North Carolina. Founded in 2018 and operating commercially since its 2022 seed round, the company runs the Atlas platform, a self-service marketplace that connects healthcare data partners (hospitals, imaging centers, and health systems across North America, Asia, Latin America, and increasingly Africa) with AI developers who need large, diverse, de-identified medical datasets for training, validation, and regulatory submissions. Atlas 2 provides searchable access to over 20 million imaging studies with an additional 30 million in progress or contracting, expanded DICOM tag support, series-level metadata, longitudinal patient-level search, and 48-hour delivery of machine-learning-ready data. The platform has been extended beyond imaging into multimodal data including EHR, pathology, laboratory, and ECG inputs.

The company operates a hybrid go-to-market combining a product-led self-serve funnel (7-day free trial, in-platform search and ordering) with enterprise field sales for large foundation-model and regulatory-grade buyers. Revenue is generated through subscription-based Atlas access, data licensing to AI developers, and revenue-sharing with data partners whose assets are used in customer projects, with pricing quoted per engagement. Distribution extends through Google Cloud Marketplace and channel partnerships including Protege (which generated seven-figure net new licensing revenue for Gradient in under a year) and Flywheel. Gradient also operates academic and research-oriented offerings including the Open Access Initiative for universities such as Stanford and Duke, and co-developed the ReXGradient-160K dataset and ReXrank public benchmark with Harvard Medical School's Rajpurkar Lab. The company is HIPAA- and SOC 2 Type 2-certified, has raised roughly $5.25M across disclosed seed rounds in 2022 and 2023, acquired DataAppraisal in 2024, and is led by CEO Josh Miller and CSO/co-founder Ouwen Huang alongside a CRO, CDO, and CPO.

Short descriptiontext

Gradient Health operates the Atlas platform, providing AI developers self-serve access to 20M+ de-identified medical imaging and multimodal clinical datasets sourced from a global hospital partner network for training, validation, and regulatory submissions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging data, healthcare data platform, de-identified datasets, multimodal clinical data, AI training data
Industry4 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAALAE
Dataset Discovery, Marketplaces & Licensing
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools
NAICS code3 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Processing & Data Preparation7374
Product category
Medical Imaging Data Platform
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Subscription Services
TypeSubscription Recurring
Description

Atlas platform subscription model where AI developers and companies pay recurring fees to access medical imaging and multimodal datasets. Initial period runs for one year with automatic month-to-month renewal thereafter. Subscription tiers determined by usage volume and data requirements.

gradienthealth.io
2Data Licensing
TypeLicensing Royalties
Description

Revenue generated from licensing de-identified medical datasets to AI developers for training, validation, regulatory submissions, and foundation model development. Data partners receive revenue share when their data is used in customer projects.

gradienthealth.io
3Platform Access Fees
TypeSubscription Recurring
Description

Fees charged for Atlas platform access beyond the Trial Period. Trial Period begins upon account creation with free access; conversion to paid subscription required for continued access.

gradienthealth.io
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Free 7-day trial with platform access
ModelFreemiumBilling cadencePay-as-you-go
Notes

7-day free trial allows AI developers to search millions of datasets, build cohorts, and evaluate fit before committing. Trial starts immediately after application approval, typically reviewed within 24 hours.

gradienthealth.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Atlas
Description

Self-service medical imaging data platform for AI developers providing access to de-identified imaging, EHR, and multimodal datasets.

gradienthealth.io
+1 more record
Core offering1 text field

Gradient Health operates the Atlas platform, a self-service medical imaging and multimodal clinical data platform that connects healthcare data partners with AI developers. The platform provides access to 20+ million de-identified imaging studies (with 30+ million more in progress or contracting), supports search by hundreds of DICOM tags, longitudinal cohort building, and delivers machine-learning-ready datasets in as little as 48 hours. Atlas has expanded beyond imaging to include EHR, pathology, laboratory, and ECG data for multimodal medical AI development, training, validation, and regulatory submissions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 20+ million imaging studies available immediately with 30M+ additional in progress or contracting
+3 more records
Product overview1 text field

Gradient Health operates as a healthcare data platform offering access to de-identified medical datasets for AI development. The core product is Atlas (now in version 2), a self-service platform providing searchable access to millions of medical imaging studies, radiology reports, and longitudinal patient data. Atlas has expanded beyond imaging to include multimodal data capabilities covering EHR, pathology, labs, and ECG. The platform connects healthcare data partners with AI developers, enabling dataset discovery, cohort building, and export for model training, validation, and regulatory submissions. Associated offerings include the ReXGradient-160K dataset and ReXrank benchmark developed with Harvard's Rajpurkar Lab, plus an Open Access Initiative for academic researchers.

Product and service3 records
1Atlas (including Atlas 2)
CategoryMedical Imaging Data Platform
2ReXGradient-160K Dataset
CategoryPublic Medical Dataset
3ReXrank Benchmark
CategoryPublic AI Benchmark
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-06
Description

Strategic partnership announced November 6, 2025 enabling imaging providers to share de-identified medical data for AI development through DataFirst's Silverback Workflow Engine and Gradient's Atlas platform. Partnership aims to address health inequalities by making it easier for providers of all sizes to participate in medical AI innovation.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Partnership making Gradient Health imaging datasets available through Protege's AI training data platform, enabling multimodal and longitudinal dataset creation for developers in oncology, radiology, and chronic disease management. Protege highlighted partnership generated seven-figure net new licensing revenue for Gradient in under one year.

Strategic tierSupportingTypeTechnology or Integration
Description

Partnership announced to integrate Gradient Health medical imaging data with Flywheel's data management platform for AI development workflows.

4Rajpurkar Lab at Harvard Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration producing ReXGradient-160K, the largest publicly available chest X-ray dataset with 160,000 studies from 109,000+ patients across 3 U.S. health systems and 79 medical sites. Also collaborated on ReXrank benchmark for AI radiology report generation evaluation.

gradienthealth.io
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership through Open Access Initiative where Kevin Wu and Eric Wu investigate bias within radiology AI using Gradient's diverse chest X-ray datasets. Stanford received over 10,000 chest X-ray images for bias research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership where Dr. Josh Helmkamp partners with Gradient Health to further research into orthopedics through the Open Access Initiative.

Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Atlas platform available on Google Cloud Marketplace for convenient access and procurement by GCP customers.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Segmed is a medical imaging data marketplace that provides de-identified, structured imaging datasets to AI developers and life sciences companies. It is the closest direct competitor to Gradient Health's Atlas platform, with overlapping customer segments in medical AI startups, foundation model teams, and clinical research organizations.

TypeDirect peer
Description

MedCognetics provides de-identified medical imaging datasets and AI training data services for healthcare AI developers. It competes head-to-head with Gradient in sourcing and licensing imaging data for training and validation of clinical AI models.

3Tempus Labs
TypeBroad incumbent
Description

Tempus is a large-scale healthcare data and AI platform that aggregates multimodal clinical, molecular, and imaging data for precision medicine. While broader than Gradient's imaging-first focus, it overlaps on the multimodal clinical data licensing use case for AI developers and life sciences customers.

TypeBroad incumbent
Description

Health Catalyst is a healthcare data and analytics platform serving health systems with large-scale clinical data assets. It is a broad incumbent in healthcare data licensing and analytics, with growing overlap into the AI training and validation use cases Gradient serves.

TypeBroad incumbent
Description

IQVIA is the largest real-world data and real-world evidence provider, offering extensive clinical and claims datasets to life sciences and AI developers. While focused on RWD/RWE rather than imaging, it competes for the same enterprise AI and pharma budget Gradient targets with Atlas.

TypeEmerging player
Description

Owkin is a federated learning and AI platform for medical research that aggregates multimodal hospital data (imaging, pathology, omics) for AI model development. It is an emerging player intersecting with Gradient's multimodal medical AI data thesis, with a stronger focus on federated research collaborations.

TypeEmerging player
Description

Cota provides real-world oncology data and analytics to life sciences companies and AI developers. It has partial overlap with Gradient's clinical data licensing for AI development, particularly in oncology cohorts where Gradient has multimodal expansion plans.

TypeOthers
Description

Flywheel is a medical imaging data management and AI development platform for research and clinical teams. It is a Gradient technology and integration partner (rather than a direct competitor) and represents the broader category of imaging data infrastructure Gradient targets as a complement or alternative.

TypeOthers
Description

Protege is an AI training data platform that licenses datasets (including Gradient's imaging data) to AI developers. It is a Gradient distribution partner rather than a competitor, but is thematically comparable as a data marketplace platform for AI model development.

TypeRegional player
Description

Rad AI is a radiology AI company that builds and deploys clinical AI models for radiology reporting. While it is primarily a downstream AI consumer of medical imaging data (and thus a Gradient customer/peer in the medical AI ecosystem), it represents the type of foundation model-adjacent customer Gradient explicitly targets in its enterprise segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gradient Health

Medical Imaging Data Platformgradienthealth.io

Gradient Health operates the Atlas platform, providing AI developers self-serve access to 20M+ de-identified medical imaging and multimodal clinical datasets sourced from a global hospital partner network for training, validation, and regulatory submissions.

What Gradient Health does

Gradient Health, Inc. is a Delaware-incorporated medical AI data platform headquartered in Durham, North Carolina. Founded in 2018 and operating commercially since its 2022 seed round, the company runs the Atlas platform, a self-service marketplace that connects healthcare data partners (hospitals, imaging centers, and health systems across North America, Asia, Latin America, and increasingly Africa) with AI developers who need large, diverse, de-identified medical datasets for training, validation, and regulatory submissions. Atlas 2 provides searchable access to over 20 million imaging studies with an additional 30 million in progress or contracting, expanded DICOM tag support, series-level metadata, longitudinal patient-level search, and 48-hour delivery of machine-learning-ready data. The platform has been extended beyond imaging into multimodal data including EHR, pathology, laboratory, and ECG inputs.

The company operates a hybrid go-to-market combining a product-led self-serve funnel (7-day free trial, in-platform search and ordering) with enterprise field sales for large foundation-model and regulatory-grade buyers. Revenue is generated through subscription-based Atlas access, data licensing to AI developers, and revenue-sharing with data partners whose assets are used in customer projects, with pricing quoted per engagement. Distribution extends through Google Cloud Marketplace and channel partnerships including Protege (which generated seven-figure net new licensing revenue for Gradient in under a year) and Flywheel. Gradient also operates academic and research-oriented offerings including the Open Access Initiative for universities such as Stanford and Duke, and co-developed the ReXGradient-160K dataset and ReXrank public benchmark with Harvard Medical School's Rajpurkar Lab. The company is HIPAA- and SOC 2 Type 2-certified, has raised roughly $5.25M across disclosed seed rounds in 2022 and 2023, acquired DataAppraisal in 2024, and is led by CEO Josh Miller and CSO/co-founder Ouwen Huang alongside a CRO, CDO, and CPO.

Gradient Health firmographics

Firmographics
Name
Gradient Health
Legal name
Gradient Health, Inc.
Website
https://gradienthealth.io
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Gradient Health operates the Atlas platform, providing AI developers self-serve access to 20M+ de-identified medical imaging and multimodal clinical datasets sourced from a global hospital partner network for training, validation, and regulatory submissions.
Ownership category
akta.pro rank

Gradient Health industry classification

Industry
Product category
Medical Imaging Data Platform
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAALAE
Dataset Discovery, Marketplaces & Licensing
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools

Keywords

  • Medical imaging data
  • Healthcare data platform
  • De-identified datasets
  • Multimodal clinical data
  • AI training data

Where Gradient Health is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Gradient Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Subscription Services: Atlas platform subscription model where AI developers and companies pay recurring fees to access medical imaging and multimodal datasets. Initial period runs for one year with automatic month-to-month renewal thereafter. Subscription tiers determined by usage volume and data requirements.
  2. Data Licensing: Revenue generated from licensing de-identified medical datasets to AI developers for training, validation, regulatory submissions, and foundation model development. Data partners receive revenue share when their data is used in customer projects.
  3. Platform Access Fees: Fees charged for Atlas platform access beyond the Trial Period. Trial Period begins upon account creation with free access; conversion to paid subscription required for continued access.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree 7-day trial with platform access

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Gradient Health product offering

Product offering

Core offering

Gradient Health operates the Atlas platform, a self-service medical imaging and multimodal clinical data platform that connects healthcare data partners with AI developers. The platform provides access to 20+ million de-identified imaging studies (with 30+ million more in progress or contracting), supports search by hundreds of DICOM tags, longitudinal cohort building, and delivers machine-learning-ready datasets in as little as 48 hours. Atlas has expanded beyond imaging to include EHR, pathology, laboratory, and ECG data for multimodal medical AI development, training, validation, and regulatory submissions.

Product overview

Gradient Health operates as a healthcare data platform offering access to de-identified medical datasets for AI development. The core product is Atlas (now in version 2), a self-service platform providing searchable access to millions of medical imaging studies, radiology reports, and longitudinal patient data. Atlas has expanded beyond imaging to include multimodal data capabilities covering EHR, pathology, labs, and ECG. The platform connects healthcare data partners with AI developers, enabling dataset discovery, cohort building, and export for model training, validation, and regulatory submissions. Associated offerings include the ReXGradient-160K dataset and ReXrank benchmark developed with Harvard's Rajpurkar Lab, plus an Open Access Initiative for academic researchers.

Differentiator

Problem solved

Functional benefit

Brands

  • Atlas: Self-service medical imaging data platform for AI developers providing access to de-identified imaging, EHR, and multimodal datasets.
  • Atlas 2

Products and services

  • Atlas (including Atlas 2)
  • ReXGradient-160K Dataset
  • ReXrank Benchmark

Quantifiable outcome

  • 20+ million imaging studies available immediately with 30M+ additional in progress or contracting
  • +3 more outcomes

Companies that use Gradient Health

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Gradient Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature5 records

Gradient Health partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and supporting.

  • DataFirstcoreStrategic or Co-development Partner · 6 November 2025Strategic partnership announced November 6, 2025 enabling imaging providers to share de-identified medical data for AI development through DataFirst's Silverback Workflow Engine and Gradient's Atlas platform. Partnership aims to address health inequalities by making it easier for providers of all sizes to participate in medical AI innovation.
  • ProtegecoreGTM or Marketing PartnerPartnership making Gradient Health imaging datasets available through Protege's AI training data platform, enabling multimodal and longitudinal dataset creation for developers in oncology, radiology, and chronic disease management. Protege highlighted partnership generated seven-figure net new licensing revenue for Gradient in under one year.
  • FlywheelsupportingTechnology or IntegrationPartnership announced to integrate Gradient Health medical imaging data with Flywheel's data management platform for AI development workflows.
  • Rajpurkar Lab at Harvard Medical SchoolcoreStrategic or Co-development PartnerResearch collaboration producing ReXGradient-160K, the largest publicly available chest X-ray dataset with 160,000 studies from 109,000+ patients across 3 U.S. health systems and 79 medical sites. Also collaborated on ReXrank benchmark for AI radiology report generation evaluation.
  • Stanford UniversitycoreStrategic or Co-development PartnerAcademic research partnership through Open Access Initiative where Kevin Wu and Eric Wu investigate bias within radiology AI using Gradient's diverse chest X-ray datasets. Stanford received over 10,000 chest X-ray images for bias research.
  • Duke UniversitycoreStrategic or Co-development PartnerAcademic research partnership where Dr. Josh Helmkamp partners with Gradient Health to further research into orthopedics through the Open Access Initiative.
  • Google Cloud MarketplacesupportingChannel Partner/ Reseller/ DistributorAtlas platform available on Google Cloud Marketplace for convenient access and procurement by GCP customers.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Gradient Health competitors and assessment

Company assessment

Direct peers

  • Segmed: Segmed is a medical imaging data marketplace that provides de-identified, structured imaging datasets to AI developers and life sciences companies. It is the closest direct competitor to Gradient Health's Atlas platform, with overlapping customer segments in medical AI startups, foundation model teams, and clinical research organizations.
  • MedCognetics: MedCognetics provides de-identified medical imaging datasets and AI training data services for healthcare AI developers. It competes head-to-head with Gradient in sourcing and licensing imaging data for training and validation of clinical AI models.

Broad incumbents

  • Tempus Labs: Tempus is a large-scale healthcare data and AI platform that aggregates multimodal clinical, molecular, and imaging data for precision medicine. While broader than Gradient's imaging-first focus, it overlaps on the multimodal clinical data licensing use case for AI developers and life sciences customers.
  • Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving health systems with large-scale clinical data assets. It is a broad incumbent in healthcare data licensing and analytics, with growing overlap into the AI training and validation use cases Gradient serves.
  • IQVIA: IQVIA is the largest real-world data and real-world evidence provider, offering extensive clinical and claims datasets to life sciences and AI developers. While focused on RWD/RWE rather than imaging, it competes for the same enterprise AI and pharma budget Gradient targets with Atlas.

Emerging players

  • Owkin: Owkin is a federated learning and AI platform for medical research that aggregates multimodal hospital data (imaging, pathology, omics) for AI model development. It is an emerging player intersecting with Gradient's multimodal medical AI data thesis, with a stronger focus on federated research collaborations.
  • Cota Healthcare: Cota provides real-world oncology data and analytics to life sciences companies and AI developers. It has partial overlap with Gradient's clinical data licensing for AI development, particularly in oncology cohorts where Gradient has multimodal expansion plans.

Others

  • Flywheel: Flywheel is a medical imaging data management and AI development platform for research and clinical teams. It is a Gradient technology and integration partner (rather than a direct competitor) and represents the broader category of imaging data infrastructure Gradient targets as a complement or alternative.
  • Protege: Protege is an AI training data platform that licenses datasets (including Gradient's imaging data) to AI developers. It is a Gradient distribution partner rather than a competitor, but is thematically comparable as a data marketplace platform for AI model development.

Regional players

  • Rad AI: Rad AI is a radiology AI company that builds and deploys clinical AI models for radiology reporting. While it is primarily a downstream AI consumer of medical imaging data (and thus a Gradient customer/peer in the medical AI ecosystem), it represents the type of foundation model-adjacent customer Gradient explicitly targets in its enterprise segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Gradient Health social profiles

Digital presence

Gradient Health compliance and trust

Trust signal

Compliance2 records

Gradient Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gradient Health leadership team

Management profile

Number of profiles

Profiles5 records

Gradient Health subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Gradient Health funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gradient Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gradient Health

What does Gradient Health do?

Gradient Health operates the Atlas platform, a self-service medical imaging and multimodal clinical data platform that connects healthcare data partners with AI developers. The platform provides access to 20+ million de-identified imaging studies (with 30+ million more in progress or contracting), supports search by hundreds of DICOM tags, longitudinal cohort building, and delivers machine-learning-ready datasets in as little as 48 hours. Atlas has expanded beyond imaging to include EHR, pathology, laboratory, and ECG data for multimodal medical AI development, training, validation, and regulatory submissions.

Is Gradient Health a public or private company?

Gradient Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Gradient Health founded?

Gradient Health was founded in 2021. It employs 11 to 50 people.

Where is Gradient Health based?

Gradient Health is headquartered in Durham, United States, in the North America region.

How does Gradient Health make money?

Three revenue lines are on record. Subscription Services are the primary driver. The others are data Licensing and platform Access Fees.

Who are Gradient Health's main competitors?

Direct peers on record are Segmed and MedCognetics. Broad incumbents are Tempus Labs, Health Catalyst and IQVIA. Emerging players are Owkin and Cota Healthcare. Others are Flywheel and Protege. Rad AI is listed as a regional player.

Does Gradient Health have an API?

No public API is recorded for Gradient Health.

What industry is Gradient Health in?

Gradient Health's product category is Medical Imaging Data Platform. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 54171 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Imaging Technology NewsGradient Health Releases Upgrade to Self-Service Medical Imaging Data PlatformGradient Health, Inc. released Atlas 2, a major upgrade to its self-service medical imaging data platform for AI developers, featuring expanded DICOM tag support, deeper search capabilities, and improved collaboration tools. The new version provides immediate access to more than 20 million imaging studies with an additional 30 million in progress or contracting. The company is showcasing Atlas 2 at RSNA 2025 in Chicago and offering a free 7-day trial for developers.Imaging Technology NewsGradient Health, DataFirst Team Up to Expand Access for AIGradient Health and DataFirst announced a strategic partnership on November 6, 2025, designed to enable imaging providers to share de-identified medical data for AI development. Through this collaboration, healthcare institutions using DataFirst's Silverback Workflow Engine can contribute data via Gradient's Atlas platform, creating new revenue opportunities while advancing more representative medical AI systems. The partnership aims to address health inequalities by making it easier for providers of all sizes to participate in medical AI innovation.Gradient HealthGradient Health Partners with Protege to Integrate Medical Imaging Data for AI TrainingProtege and Gradient Health announced a partnership to integrate medical imaging data, providing developers with access to millions of de-identified images for AI training. This collaboration aims to accelerate the creation of robust healthcare AI models, particularly in oncology and radiology, by addressing the bottleneck of high-quality training data.HIT ConsultantGradient Health Acquires DataAppraisal to Expand Medical AIGradient Health acquired DataAppraisal, a healthcare AI company that provides anonymized medical imaging data. The deal expands Gradient Health's repository of de-identified studies, including datasets from rural and underserved U.S. communities, to support AI model development. Financial terms were not disclosed.GrepBeatGradient Health’s SaaS Platform Turbocharges Medical Research ProcessGradient Health, a Durham-based startup, offers a SaaS platform that anonymizes patient data for medical research. The company has collected over 300 million patient studies from 10 countries and raised $5.6 million. It is expanding beyond radiology into pathology and genomics.Pulse 2.0Gradient Health: Medical AI Data-Sharing Company Raises $2.75 MillionGradient Health closed a $2.75 million funding round led by ReMY Investors & Consultants, with participation from Boro Capital, Supernode Ventures, and others. The capital will be used to expand its secure platform for annotated medical imaging data, aiming to support AI development in healthcare.SecSEC FORM DGradient Health, Inc. filed a Form D with the U.S. Securities and Exchange Commission for an exempt offering of securities under Rule 506(b), with total proceeds reaching $2,424,998 USD out of a $2,750,000 USD target. The filing lists nine investors and indicates that up to $250,000 USD of the gross proceeds may be used for officer salaries.PR NewswireCreating the world's largest medical imaging library - Gradient Health closes $2.75M roundGradient Health closed a $2.75 million funding round led by ReMY Investors & Consultants, with participation from Boro Capital, Supernode Ventures, and others. The investment will support assembling its annotated medical imaging library into a secure, unified platform for medical AI research.FinSMEsGradient Health Closes $2.75M Funding RoundGradient Health, a Raleigh-based medical AI data-sharing company, has closed a $2.75 million funding round led by ReMY Investors and Consultants with participation from several other venture firms and individual investors. The company plans to utilize these funds to expand its secure, unified platform for annotated medical imaging libraries. This capital injection supports the company's ongoing efforts to facilitate compliant research and collaboration within the healthcare technology sector.DOTmedRhisa and Gradient Health partner to help break down borders for medical innovatorsRhisa and Gradient Health announced a partnership to provide diverse medical imaging data for AI training, addressing regulatory concerns about small datasets. The collaboration spans Europe and North America, enabling researchers to access compliant data quickly and securely. The companies aim to accelerate medical innovation with highly qualified data.